ConductScience.org, home

Paper36924097

Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics.

Ning Y and 4 others. Protein Pept Lett, 2023. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics. Papers, record 36924097. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36924097

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Antimicrobial Peptides: A Promising Strategy for Anti-tuberculosis Therapeutics.
PubMed
Journal
Protein Pept Lett
PubMed
Year
2023
PubMed
Publication types
Review, Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.63
iCite
Revised in PubMed
2023-06-01
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ning YYu
2Wang LLujuan
3Wang MMenglu
4Meng XXiangying
5Qiao JJinjuan

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
TuberculosisMajor topic
Mycobacterium tuberculosisMajor topic
Humans
Antitubercular Agents
Antimicrobial Peptides
Anti-Bacterial Agents
Antimicrobial Cationic Peptides

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
No. 2019WS593,No. ZR2020MH305,ZR2020MH305,ZR2020MH305,No. ZR2020MH305Natural Science Foundation of Shandong ProvincePubMed

Source PubMed

Download CSV of grants

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42777046Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination.Sci Adv2026https://conductscience.org/library/papers/42777046PubMed
41155557Peptide-Based Strategies Against Mycobacterium tuberculosis Covering Immunomodulation, Vaccines, Synergistic Therapy, and Nanodelivery.Pharmaceuticals (Basel)2025https://conductscience.org/library/papers/41155557PubMed
40676307Unveiling the potential of antimicrobial peptides to combat Mycobacterium tuberculosis.Arch Microbiol2025https://conductscience.org/library/papers/40676307PubMed
40498301Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis.Probiotics Antimicrob Proteins2026https://conductscience.org/library/papers/40498301PubMed
38412510Tertiary Plasticity Drives the Efficiency of Enterocin 7B Interactions with Lipid Membranes.J Phys Chem B2024https://conductscience.org/library/papers/38412510PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36924097

GET https://conductscience.org/api/papers/v1/36924097/authors